novo nordisk semaglutide direct Canada approves generic from Dr. Reddy's, a G7 first enabled by Nordisk's lapsed CAD$250 patent Novo Nordisk unveils $499 cash-pay

Medicare, as of April 2026, does not pay for FDA-approved weight-loss drugs on the basis of weight alone, though certain cardiovascular indications are covered for some products

Therefore, the aim of this review was to synthesise existing evidence and characterise the typical trajectory of weight regain following cessation of GLP-1RA treatment

They're not at this time considered right for everyone

If fatigue severely limits daily activities, notify your healthcare team

The side effect profile varies widely because genetic factors influence how your body processes GLP-1 signals

Glutathione constipation occurs when high-dose oral glutathione (typically 500mg or more daily) alters intestinal motility by reducing oxidative signaling in smooth muscle cells and shifting gut microbiome composition toward species that produce less butyrate